Literature DB >> 26976881

Bacteriology of Naja atra Snakebite Wound and Its Implications for Antibiotic Therapy.

Yan-Chiao Mao1, Po-Yu Liu1, Dong-Zong Hung1, Wei-Cheng Lai1, Shih-Ting Huang1, Yao-Min Hung1, Chen-Chang Yang2.   

Abstract

A total of 112 cases of Naja atra envenomation were examined at two referring hospitals: Taichung Veterans General Hospital in central Taiwan and Taipei Veterans General Hospital (VGH-TP) in northern Taiwan. Overall, 77% (86/112) of cases developed clinically suspected wound infections and 54% (61/112) required surgery secondary to tissue necrosis, finger or toe gangrene, and/or necrotizing fasciitis. Morganella morganii was the most abundant gram-negative bacterial strain isolated from bite wounds, followed by Proteus spp., Aeromonas hydrophila, Pseudomonas aeruginosa, and Providencia spp. in descending order; Enterococcus spp. were the most common gram-positive bacteria and Bacteroides spp. were the only anaerobic bacteria. A few episodes of bacteremia were caused by Bacteroides and Shewanella spp. There were no significant variations in the distribution of bacterial species between these two hospitals except for a higher incidence of M. morganii, Enterococcus spp., and polymicrobial infection observed at VGH-TP, which may have been related to variations in the fecal flora of prey and oral flora of individual snakes in different geographic areas in Taiwan. According to the susceptibility test involving various pathogens, first-line drug options for the management of N. atra snakebite wound infections may include monotherapy with ureidopenicillin or combination therapy with aminopenicillin and a third-generation cephalosporin or fluoroquinolone. A prospective evaluation of empiric antibiotic therapy for the management of N. atra snakebite should be considered. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26976881      PMCID: PMC4856614          DOI: 10.4269/ajtmh.15-0667

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  The role of sulfatide lipid domains in the membrane pore-forming activity of cobra cardiotoxin.

Authors:  Po-Long Wu; Chang-Ru Chiu; Wei-Ning Huang; Wen-Guey Wu
Journal:  Biochim Biophys Acta       Date:  2012-02-23

2.  Wound infections secondary to snakebite.

Authors:  Atul Garg; S Sujatha; Jaya Garg; N Srinivas Acharya; Subhash Chandra Parija
Journal:  J Infect Dev Ctries       Date:  2009-04-30       Impact factor: 0.968

3.  Membrane-damaging activity of Taiwan cobra cardiotoxin 3 is responsible for its bactericidal activity.

Authors:  Li-Wen Chen; Pei-Hsiu Kao; Yaw-Syan Fu; Shinne-Ren Lin; Long-Sen Chang
Journal:  Toxicon       Date:  2011-05-07       Impact factor: 3.033

Review 4.  Microbiology of animal bite wound infections.

Authors:  Fredrick M Abrahamian; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Bacterial infection in association with snakebite: a 10-year experience in a northern Taiwan medical center.

Authors:  Chun-Ming Chen; Keh-Gong Wu; Chun-Jen Chen; Chuang-Ming Wang
Journal:  J Microbiol Immunol Infect       Date:  2011-06-22       Impact factor: 4.399

6.  Antibiotic use and infection in snakebite victims.

Authors:  R S Blaylock
Journal:  S Afr Med J       Date:  1999-08

7.  A cross-sectional survey of snake oral bacterial flora from Hong Kong, SAR, China.

Authors:  Ka Keung Lam; Paul Crow; Kenneth Ho Leung Ng; Kam Chuen Shek; Hin Tat Fung; Gary Ades; Alessandro Grioni; Kit Sun Tan; Kam Tong Yip; David Christopher Lung; Tak Lun Que; Tommy Shing Kit Lam; Ian D Simpson; Kwok Leung Tsui; Chak Wah Kam
Journal:  Emerg Med J       Date:  2010-05-29       Impact factor: 2.740

8.  Five-year experience with Chinese cobra (Naja atra)--related injuries in two acute hospitals in Hong Kong.

Authors:  O F Wong; T S K Lam; H T Fung; C H Choy
Journal:  Hong Kong Med J       Date:  2010-02       Impact factor: 2.227

9.  Differences in clinical profiles of patients with Protobothrops mucrosquamatus and Viridovipera stejnegeri envenoming in Taiwan.

Authors:  Yen-Wen Chen; Min-Hui Chen; Yen-Chia Chen; Dong-Zong Hung; Chien-Kuang Chen; David Hung-Tsang Yen; Chun-I Huang; Chen-Hsen Lee; Lee-Min Wang; Chen-Chang Yang
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

10.  Clinical significance of and outcomes for Bacteroides fragilis bacteremia.

Authors:  Chun-Wen Cheng; Huang-Shen Lin; Jung-Jr Ye; Chien-Chang Yang; Ping-Cherng Chiang; Ting-Shu Wu; Ming-Hsun Lee
Journal:  J Microbiol Immunol Infect       Date:  2009-06       Impact factor: 4.399

View more
  20 in total

1.  Bungarus multicinctus multicinctus Snakebite in Taiwan.

Authors:  Yan-Chiao Mao; Po-Yu Liu; Liao-Chun Chiang; Shu-Chen Liao; Hung-Yuan Su; Szu-Yin Hsieh; Chen-Chang Yang
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Bacterial Adaptation to Venom in Snakes and Arachnida.

Authors:  Elham Esmaeilishirazifard; Louise Usher; Carol Trim; Hubert Denise; Vartul Sangal; Gregory H Tyson; Axel Barlow; Keith F Redway; John D Taylor; Myrto Kremyda-Vlachou; Sam Davies; Teresa D Loftus; Mikaella M G Lock; Kstir Wright; Andrew Dalby; Lori A S Snyder; Wolfgang Wuster; Steve Trim; Sterghios A Moschos
Journal:  Microbiol Spectr       Date:  2022-05-23

3.  Envenomation by Trimeresurus stejnegeri stejnegeri: clinical manifestations, treatment and associated factors for wound necrosis.

Authors:  Liao-Chun Chiang; Wei-Jen Tsai; Po-Yu Liu; Cheng-Hsuan Ho; Hung-Yuan Su; Chih-Sheng Lai; Kuo-Lung Lai; Wen-Loung Lin; Chi-Hsin Lee; Yi-Yuan Yang; Uyen Vy Doan; Tri Maharani; Yan-Chiao Mao
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-09-18

4.  Serum Procalcitonin Concentration and Its Relationship with Local Manifestations after Snakebites.

Authors:  Chanaveerappa Bammigatti; Preetham A Reddy; Nandeesha Hanumanthappa; K T Harichandrakumar; Rathinam Palamalai Swaminathan
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

5.  Comparative Genome Analysis of Uropathogenic Morganella morganii Strains.

Authors:  Leyla Minnullina; Daria Pudova; Elena Shagimardanova; Leyla Shigapova; Margarita Sharipova; Ayslu Mardanova
Journal:  Front Cell Infect Microbiol       Date:  2019-05-22       Impact factor: 5.293

6.  Wound Infections of Snakebites from the Venomous Protobothrops mucrosquamatus and Viridovipera stejnegeri in Taiwan: Bacteriology, Antibiotic Susceptibility, and Predicting the Need for Antibiotics-A BITE Study.

Authors:  Chih-Chuan Lin; Yen-Chia Chen; Zhong Ning Leonard Goh; Chen-Ken Seak; Joanna Chen-Yeen Seak; Gao Shi-Ying; Chen-June Seak
Journal:  Toxins (Basel)       Date:  2020-09-07       Impact factor: 4.546

7.  Next-generation sequencing analysis reveals high bacterial diversity in wild venomous and non-venomous snakes from India.

Authors:  Sajesh Puthenpurackal Krishnankutty; Megha Muraleedharan; Rajadurai Chinnasamy Perumal; Saju Michael; Jubina Benny; Bipin Balan; Pramod Kumar; Jishnu Manazhi; Bangaruswamy Dhinoth Kumar; Sam Santhosh; George Thomas; Ravi Gupta; Arun Zachariah
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-12-22

8.  Antibiotic therapy for snakebite envenoming.

Authors:  Dabor Resiere; José María Gutiérrez; Rémi Névière; André Cabié; Mehdaoui Hossein; Hatem Kallel
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-02-03

9.  Infectious Complications Following Snakebite by Bothrops lanceolatus in Martinique: A Case Series.

Authors:  Dabor Resiere; Hossein Mehdaoui; Rémi Névière; Claude Olive; Mathieu Severyns; Adeline Beaudoin; Jonathan Florentin; Yannick Brouste; Rishika Banydeen; André Cabié; Bruno Mégarbane; José María Gutiérrez; Hatem Kallel
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

10.  Wound Infections from Taiwan Cobra (Naja atra) Bites: Determining Bacteriology, Antibiotic Susceptibility, and the Use of Antibiotics-A Cobra BITE Study.

Authors:  Heng Yeh; Shi-Ying Gao; Chih-Chuan Lin
Journal:  Toxins (Basel)       Date:  2021-03-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.